From DCAT Value Chain Insights (VCI)
Cerbios-Pharma SA has appointed Annalisa Miracca as director of marketing and sales of the company's Chemical Division. Cerbios is a privately held company located in Lugano, Switzerland, which specializes in the development and manufacture of both chemical and biological APIs for its partners worldwide. Active pharmaceutical ingredients (APIs) made by Cerbios include small molecules (Chemical Division) and large molecules and probiotics (Biological Division).
In her role, Mrs. Miracca is responsible for the marketing and sales of commercial chemical APIs, for the development of
sales in existing and emerging markets, and for customer acquisitions. She also is responsible for negotiating sale prices and concluding new trade agreements as well as the preparation of forecast and periodic analyses of risks and opportunities.
Mrs. Miracca holds a degree in chemistry from the University of Pavia and has been active in the chemical and pharmaceutical industry since 1997. After short periods spent in quality-control laboratories of different companies, she started her experience in marketing and sales in 1997, when she joined the Italian subsidiary of Sigma-Aldrich, where she also took responsibility of the import and sales of controlled substances. Her carrier continued between 2001 and 2014 with Farmabios S.p.A. in the Marketing & Sales Department with responsibility for sales in different countries. She succeeds Peter Buchs who is retiring.
Thank you for reading DCAT Value Chain Insights (VCI), an information resource from the
Drug, Chemical & Associated Technologies Association (DCAT).
Learn more and sign up to receive a complimentary subscription